Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 150 | 165 | 163 | 205 | 156 |
| Gross Profit | 150 | 165 | 163 | 205 | 156 |
| Operating Expenses | 12,722 | 12,766 | 12,708 | 11,138 | 10,488 |
| Operating Income | -12,572 | -12,601 | -12,545 | -10,933 | -10,332 |
| Other Income | 785 | 746 | 767 | 922 | 995 |
| Pre-tax Income | -11,787 | -11,855 | -11,778 | -10,011 | -9,337 |
| Net Income Continuous | -11,787 | -11,855 | -11,778 | -10,011 | -9,337 |
| Net Income | $-11,787 | $-11,855 | $-11,778 | $-10,011 | $-9,337 |
| EPS Basic Total Ops | -0.22 | -0.25 | -0.26 | -0.22 | -0.21 |
| EPS Basic Continuous Ops | -0.21 | -0.25 | -0.26 | -0.22 | -0.21 |
| EPS Diluted Total Ops | -0.22 | -0.25 | -0.26 | -0.22 | -0.21 |
| EPS Diluted Continuous Ops | -0.21 | -0.25 | -0.26 | -0.22 | -0.21 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.25 | -0.26 | -0.22 | N/A |
| EBITDA(a) | $-12,634 | $-12,657 | $-12,567 | $-10,987 | $-10,434 |